The foundation: GnRH is the reproductive system’s master signal
The reproductive hormone system works like a carefully timed communication network.
At the top is the hypothalamus, a region of the brain that acts like a control room. It releases GnRH in short, repeating pulses. These pulses travel a short distance to the pituitary gland, which responds by releasing two key hormones:
- Luteinising hormone (LH): helps regulate ovulation and stimulates testosterone production in the testes.
- Follicle-stimulating hormone (FSH): supports ovarian follicle development and sperm production.
Together, these signals activate the gonads, the ovaries or testes, to produce sex hormones such as estradiol, progesterone and testosterone.
This three-part communication chain is called the hypothalamic–pituitary–gonadal (HPG) axis.
Think of the HPG axis as a sports team:
- The hypothalamus is the coach calling plays.
- The pituitary is the midfield distributing instructions.
- The gonads are the players carrying out the work.
- Sex hormones report back to the brain and help regulate the next play.
The timing matters. Pulsed GnRH stimulates the pituitary. Continuous GnRH-like stimulation eventually suppresses it.
That apparent contradiction is the key to understanding nafarelin.
Nafarelin’s paradox: stimulation first, suppression later
A common question is: how can a GnRH agonist reduce reproductive hormone activity if it initially stimulates the GnRH receptor?
The answer is exposure pattern.
Natural GnRH arrives as a sequence of brief pulses. Nafarelin, when administered continuously according to a prescription regimen, creates a much more persistent signal. At first, the pituitary interprets that signal as a strong command to release LH and FSH.
This is the flare phase.
After continued exposure, however, the pituitary adapts. GnRH receptors on pituitary gonadotrope cells become less responsive and are reduced in number. This process is called receptor downregulation and desensitisation.
The communication system is still receiving the signal, but the receiver has effectively turned down its volume.
The two-stage response
| Stage | What happens at the pituitary | Hormonal result |
|---|---|---|
| Initial flare | GnRH receptors are stimulated | LH and FSH temporarily rise |
| Continuous exposure | Receptors downregulate and signalling becomes less responsive | LH and FSH fall |
| Established suppression | Gonadal stimulation is reduced | Estradiol and testosterone decline |
The Pfizer Synarel prescribing information describes this sequence: nafarelin initially stimulates LH and FSH, while repeated dosing abolishes the stimulatory effect and reduces gonadal steroid production.
Short summary: the same receptor can produce opposite outcomes when the timing of the signal changes.
